Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune disorders, today announced its participation in the 2024 Stifel Healthcare ...
Analysts at Cantor Fitzgerald increased their FY2024 earnings per share estimates for Y-mAbs Therapeutics in a research note ...
Equities researchers at Wedbush increased their FY2024 earnings estimates for iTeos Therapeutics in a research report issued ...
Paulick Report on MSN18h
Watch: Do You Know What Product Your Horse Should Get For Osteoarthritis?To determine which product to use when, it is important to have a current understanding of osteoarthritis (OA). It has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback